Home > Healthcare > Analytical Instruments > Molecular Analysis > horseradish peroxidase market
Get a free sample of Horseradish Peroxidase Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Horseradish Peroxidase Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Horseradish Peroxidase Market size was valued at USD 64.1 million in 2023 and is anticipated to showcase growth at 7.5% CAGR from 2024 and 2032. Increasing demand for immunoassays in disease diagnosis, growing investments in biomedical research, and growing demand for drug development and drug quality control is driving the revenue growth in market. Additionally, advances in enzyme engineering and production are also strengthening the revenue growth in the market.
Horseradish peroxidase is an enzyme derived from the roots of the horseradish plant and belongs to the peroxidase family of enzymes. This enzyme is extensively used in various biochemical, biotechnological, and biomedical applications due to its versatile catalytic properties.
The immunoassays segment held 65.7% of the market share in 2023 and will grow rapidly through 2032, attributed to increasing use of horseradish peroxidase-based antibody assays across diagnostic testing requiring high sensitivity.
The global horseradish peroxidase market size was valued at USD 64.1 million in 2023 and is anticipated to showcase growth at 7.5% CAGR from 2024
North America horseradish peroxidase market accounted for 40.6% share in 2023 and is predicted to reach USD 47.8 million by 2032, attributed to increasing demand of horseradish peroxidase-based assays for diagnostic testing.
Abcam Limited, Abnova Corporation, BBI Solutions, Bio-rad Laboratories, Inc, Creative Enzymes, Enzo Life Sciences, Inc, F. Hoffman-La Roche Ltd., Faizyme Laboratories (Pty) Ltd, GenScript, and Merck KGaA among others.